Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE-AF
NCT07424690Recruiting
- Sponsor
- Karolinska University Hospital
- Start
- Oct 2026
- Primary completion
- Dec 2031
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Karolinska University Hospital. Primary endpoints: Composite clinical endpoint (all-cause mortality, stroke, serious bleeding, cardiac arrest, or heart failure hospitalization) at 24 months and Change in RAND-36 General Health score at 24 months. Started Oct 2026; status: recruiting.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07424690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07424690.